An effect similar to interference with Rac signaling was also observed upon addition of a Rac1 inhibitor to MDA-MB-231 human breast cancer cells, in which the invasiveness of Rac1 inhibitor-treated cancer cells was pronouncedly reduced after three days54. This evidence concerns the gene AKT1 and breast carcinoma.